Franklin Resources Inc Regeneron Pharmaceuticals, Inc. Transaction History

Franklin Resources Inc

  • $313 Billion
  • Q2 2024

A detailed history of Franklin Resources Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 1,923,102 shares of REGN stock, worth $2.18 Billion. This represents 0.64% of its overall portfolio holdings.

Number of Shares
1,923,102
Previous 1,694,298 13.5%
Holding current value
$2.18 Billion
Previous $1.63 Billion 23.95%
% of portfolio
0.64%
Previous 0.54%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$883.2 - $1071.19 $202 Million - $245 Million
228,804 Added 13.5%
1,923,102 $2.02 Billion
Q1 2024

May 13, 2024
BUY
$902.69 - $993.35 $1.09 Billion - $1.2 Billion
1,210,185 Added 249.98%
1,694,298 $1.63 Billion
Q4 2023

Feb 09, 2024
BUY
$775.18 - $881.7 $699,987 - $796,175
903 Added 0.19%
484,113 $425 Million
Q3 2023

Nov 13, 2023
SELL
$692.45 - $844.37 $3.78 Million - $4.61 Million
-5,454 Reduced 1.12%
483,210 $398 Million
Q2 2023

Aug 11, 2023
SELL
$700.03 - $830.35 $784,033 - $929,992
-1,120 Reduced 0.23%
488,664 $351 Million
Q1 2023

May 12, 2023
SELL
$680.49 - $826.97 $9.32 Million - $11.3 Million
-13,689 Reduced 2.72%
489,784 $402 Million
Q4 2022

Feb 10, 2023
SELL
$705.89 - $766.39 $16 Million - $17.4 Million
-22,724 Reduced 4.32%
503,473 $363 Million
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $867,268 - $1.09 Million
1,511 Added 0.29%
526,197 $362 Million
Q2 2022

Aug 11, 2022
SELL
$548.35 - $738.84 $21.4 Million - $28.9 Million
-39,074 Reduced 6.93%
524,686 $310 Million
Q1 2022

May 13, 2022
SELL
$595.12 - $698.43 $40.9 Million - $48 Million
-68,688 Reduced 10.86%
563,760 $394 Million
Q4 2021

Feb 11, 2022
BUY
$543.48 - $670.97 $14.6 Million - $18 Million
26,801 Added 4.43%
632,448 $399 Million
Q3 2021

Nov 12, 2021
SELL
$574.03 - $680.96 $4.1 Million - $4.86 Million
-7,138 Reduced 1.16%
605,647 $367 Million
Q2 2021

Aug 13, 2021
BUY
$472.8 - $558.54 $10.8 Million - $12.7 Million
22,781 Added 3.86%
612,785 $342 Million
Q1 2021

May 13, 2021
SELL
$446.73 - $548.2 $11.7 Million - $14.4 Million
-26,184 Reduced 4.25%
590,004 $279 Million
Q4 2020

Feb 10, 2021
SELL
$478.3 - $607.98 $49.9 Million - $63.4 Million
-104,349 Reduced 14.48%
616,188 $298 Million
Q3 2020

Nov 12, 2020
BUY
$544.75 - $658.21 $14.6 Million - $17.6 Million
26,793 Added 3.86%
720,537 $403 Million
Q2 2020

Aug 13, 2020
BUY
$493.32 - $643.92 $54.7 Million - $71.4 Million
110,879 Added 19.02%
693,744 $442 Million
Q1 2020

May 13, 2020
SELL
$336.18 - $494.43 $25.7 Million - $37.7 Million
-76,316 Reduced 11.58%
582,865 $285 Million
Q4 2019

Feb 12, 2020
SELL
$274.13 - $376.51 $11.7 Million - $16.1 Million
-42,834 Reduced 6.1%
659,181 $248 Million
Q3 2019

Nov 14, 2019
BUY
$273.46 - $318.39 $5.53 Million - $6.43 Million
20,208 Added 2.96%
702,015 $195 Million
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $33.6 Million - $46.5 Million
112,147 Added 19.69%
681,807 $213 Million
Q1 2019

May 14, 2019
SELL
$372.08 - $439.57 $3.74 Million - $4.42 Million
-10,047 Reduced 1.73%
569,660 $234 Million
Q4 2018

Feb 12, 2019
SELL
$335.82 - $403.04 $24.6 Million - $29.5 Million
-73,178 Reduced 11.21%
579,707 $217 Million
Q3 2018

Nov 13, 2018
SELL
$351.14 - $408.51 $13 Million - $15.1 Million
-37,070 Reduced 5.37%
652,885 $264 Million
Q2 2018

Aug 14, 2018
SELL
$284.6 - $344.99 $22.2 Million - $26.9 Million
-77,905 Reduced 10.15%
689,955 $238 Million
Q1 2018

May 10, 2018
SELL
$315.82 - $393.78 $16.4 Million - $20.5 Million
-51,936 Reduced 6.34%
767,860 $264 Million
Q4 2017

Feb 14, 2018
BUY
$358.63 - $469.95 $12.6 Million - $16.5 Million
35,123 Added 4.48%
819,796 $308 Million
Q3 2017

Nov 13, 2017
BUY
$431.38 - $504.0 $338 Million - $395 Million
784,673
784,673 $351 Million

Others Institutions Holding REGN

# of Institutions
1,460
Shares Held
84.5M
Call Options Held
907K
Put Options Held
1.3M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $121B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email